6533b7d1fe1ef96bd125d8ce

RESEARCH PRODUCT

European Panel on Low Density Lipoprotein (LDL) Subclasses: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

D.p. MikhailidisM. ElisafM. RizzoK. BerneisB. GriffinA. ZambonV. AthyrosJ. De GraafW. MarzK.g. ParhoferG.b. RiniG.a. SpinasG.h. TomkinA.d. TselepisA.s. WierzbickiK. WinklerM. FlorentinE. Liberopoulos

subject

cardiovascular riskischemic-heart-diseaseHealth aging / healthy living [IGMD 5]coronary-artery-diseaseapolipoprotein-b metabolismcholesteryl ester transferAtherosclerosisstatementfamilial combined hyperlipidemialdlLipoproteins LDLvery-low-densitynuclear-magnetic-resonancec-reactive proteinRisk FactorsAnimalsHumansGenetic Predisposition to DiseaseLDL subclasses atherosclerosis cardiovascular risk statementsubclassesatherosclerosistype-2 diabetes-mellitusintima-media thickness

description

Item does not contain fulltext Aim of the present Consensus Statement is to provide a comprehensive and up to-date document on the pathophysiology, atherogenicity and clinical significance of low density liproproteins (LDL) subclasses. We sub-divided our statement in 2 sections. section I discusses the pathophysiology, atherogenicity and measurement issues, while section II is focused on the effects of drug and lifestyle modifications. Suggestions for future research in the field are highlighted at the end of section II. Each section includes Conclusions.

yearjournalcountryeditionlanguage
2011-03-08
http://olympias.lib.uoi.gr/jspui/handle/123456789/10646